Literature DB >> 1659236

A randomized trial of an interim methadone maintenance clinic.

S R Yancovitz1, D C Des Jarlais, N P Peyser, E Drew, P Friedmann, H L Trigg, J W Robinson.   

Abstract

BACKGROUND: Interim methadone maintenance has been proposed as a method of providing clinically effective services to heroin addicts waiting for treatment in standard comprehensive methadone maintenance programs.
METHODS: A clinic that provided initial medical evaluation, methadone medication, and AIDS education, but did not include formal drug abuse counseling or other social support services was established in New York City. A sample of 301 volunteer subjects recruited from the waiting list for treatment in the Beth Israel methadone program were randomly assigned to immediate entry into the interim clinic or a control group.
RESULTS: There were no differences in initial levels of illicit drug use across the experimental and control groups. One-month urinalysis follow-up data showed a significant reduction in heroin use in the experimental group (from 63% positive at intake to 29% positive) with no change in the control group (62% to 60% positive). No significant change was observed in cocaine urinalyses (approximately 70% positive for both groups at intake and follow-up). A higher percentage of the experimental group were in treatment at 16-month follow-up (72% vs 56%).
CONCLUSIONS: Limited services interim methadone maintenance can reduce heroin use among persons awaiting entry into comprehensive treatment and increase the percentage entering treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659236      PMCID: PMC1405649          DOI: 10.2105/ajph.81.9.1185

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  2 in total

1.  The validity of methadone clients' self-reported drug use.

Authors:  S Magura; D Goldsmith; C Casriel; P J Goldstein; D S Lipton
Journal:  Int J Addict       Date:  1987-08

2.  Preventing AIDS in drug addicts in Amsterdam.

Authors:  E C Buning; R A Coutinho; G H van Brussel; G W van Santen; A W van Zadelhoff
Journal:  Lancet       Date:  1986-06-21       Impact factor: 79.321

  2 in total
  56 in total

1.  Administrative, clinical, and ethical issues surrounding the use of waiting lists in the delivery of mental health services.

Authors:  Seth A Brown; Jefferson D Parker; Phillip R Godding
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

2.  Drug policy reform: societal and clinical perspectives.

Authors:  R G Newman
Journal:  Bull N Y Acad Med       Date:  1995

3.  A brief telephone intervention targeting treatment engagement from a substance abuse program wait list.

Authors:  Jefferson D Parker; Cynthia L Turk; Lisa D Busby
Journal:  J Behav Health Serv Res       Date:  2002-08       Impact factor: 1.505

Review 4.  The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.

Authors:  Steven Simoens; Catriona Matheson; Christine Bond; Karen Inkster; Anne Ludbrook
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

5.  Social contextual factors associated with entry into opiate agonist treatment among injection drug users.

Authors:  Jacqueline J Lloyd; Erin P Ricketts; Steffanie A Strathdee; Llewellyn J Cornelius; David Bishai; Steven Huettner; Jennifer R Havens; Carl Latkin
Journal:  Am J Drug Alcohol Abuse       Date:  2005       Impact factor: 3.829

6.  Interim methadone clinics: an undervalued approach.

Authors:  V P Dole
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

7.  Access to drug abuse treatment under Treatment on Demand policy in San Francisco.

Authors:  James L Sorensen; Joseph Guydish; Pamela Zilavy; Thomas B Davis; Alice Gleghorn; Marvin Jacoby; Clare Sears
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

8.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.

Authors:  Jane M Liebschutz; Denise Crooks; Debra Herman; Bradley Anderson; Judith Tsui; Lidia Z Meshesha; Shernaz Dossabhoy; Michael Stein
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

Review 9.  Drug abuse treatment as AIDS prevention.

Authors:  D S Metzger; H Navaline; G E Woody
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Interim methadone treatment: impact on arrests.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Timothy W Kinlock; Michael S Gordon; Sharon M Kelly; Monique E Wilson; Ashraf Ahmed
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.